- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
Corporate Social Responsibility of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug
Posted by Matthew Harvey on Oct-17-2018
1. CSR at AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug
CSR s embedded in the business philosophy of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug. At AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug, the business operations and processes are designed in a way that they do not become an obstacle or a burden in the way of people’s and the environment’s wellbeing. At the same time, these processes and designs boost business growth. The systematic design of operations at AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug enables the management to ensure that the organization achieves sustainable business growth by reducing attached risk factors as well as through community building goals and ambitions. AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug strives to increase its social impact and influence on the environment and in people’s lives- by focusing on three big goals.
1.1. Values at AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works for CSR through the CSV approach. This is made easier to incorporate in the company systems because of the core values practised at AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug. These are:
Respect – for every one
- Trust
- Integrity
- Honesty
- Accountability
1.2. CSR goals at AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug
1.2.1. Improving livings standards for communities through increasing employment opportunities
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug believes in working for the people, and working with the people. With the growth of the business across the world, AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug ensures that it creates new employment and livelihood opportunities for millions across the globe. This is done through direct employment and contracts, as well as through inclusive business opportunities.
1.2.2. Enhancing the health and wellbeing of communities engaging with AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works with communities at large and aims to help them become healthier and happier. AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug provides nutritional boosting and support to communities where it runs operations, as well as to other communities living in regions marked below poverty. Additionally, AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug also produces and distributes health and hygiene products to enhance the wellbeing of its customers along with the various communities it has engaged with.
1.2.3. Reducing environmental footprint
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works towards reducing its environmental footprint by ensuring that it allows the legislation regarding carbon production and release. Also, AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works towards designing operational processes that reduce water and land pollution. All products manufactured and distributed by AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug come with a disposal method to reduce wastage, and increase recycling.
2. Creating shared value (CSV) at AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works hard to create value for not only the shareholders but for the society at large. This approach of creating shared value has enabled impressive business growth for AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug, as well as allowing its expansion regionally as well as in its product portfolio. Through creating shared value, AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug brings value to the lives of communities where it operates by influencing those aspects of the society which intersect and coincide with the business offerings and business operations.
2.1. How to maximize value creation?
Through the CSV approach, AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug can create the most value in the following aspects:
2.1.1. Nutrition
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug focuses on investing in the health of communities by focusing on nutrition and medication, as well as on sanitation and hygiene. The primary focus remains on ensuring health safety for children and infants.
2.1.2. Water
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works hard with third parties and external as well as internal support systems to ensure that its operations do not cause water damage. In addition, it administers all its internal sewage plants to dispose of waste optimally without risking water life.
2.1.3. Air cleansing
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug maintains carbon units as per legislation in all its operations across the globe. The company also takes responsibility for ensuring that all its industrial sites and operations are placed away from residential areas to reduce maximum exposure of plant operations to the public.
2.1.4. Rural development
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug strives to develop communities where it operates. This includes rural communities and settlements from where AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug gets its raw materials and inputs as well as labour. AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug created varied employment and livelihood opportunities for these communities to help them raise their living standards and quality of life.
3. Commitments made by AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug
Commitments at the AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug have helped shape its CSR and CSV approach based on multiple trends from across the globe. These commitments have helped AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug maintain focus in giving back to the community as well as in developing a more sustainable environment and workplace. Commitments are the long term goals that AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug wants to fulfil and achieve in the following different aspects:
3.1. For individuals and families
3.1.1. Living healthier lives
For families and communities, the CSV approach of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug focuses on helping individuals attain a balance between healthy nutrition and physical exercise as a means of a healthier lifestyle and healthy living. With today’s work style and busy schedules, this is quite a challenge. AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works intending to develop programs and products to help communities manage time well and stay motivated towards increasing their wellbeing.
3.1.2. Having nutritional knowledge
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works with the long term aspiration of enhancing the lifestyles of communities. The company plans to do it by sharing information regarding nutritional facts, and by raising awareness of nutritional intake. The company does this by not only making the nutritional value available for its own manufactured products but also develops programs and information sharing networks to help individuals learn about healthy eating and make informed dietary decisions.
3.2. For communities
3.2.1. Rural development
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works towards developing rural communities-especially where it is operational and present. The company engages not only in employment creation but also infrastructure development and education deployment programs to help communities improve their living standards. AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug also conducts vocational training programs frequently.
3.2.2. Promoting diversity
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug also works towards inclusion through its diversity programs. The company has designed programs and policies to ensure the inclusion of all community groups in the employment cycle. In addition, the company also conducts training and skill enhancement sessions for all community groups –including disabled and special persons
3.3. For the planet
3.3.1. Protecting water
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug understands the need for protecting water resources across the globe and is also an active fighter for water preservation. With the high scarcity of clean drinking water, AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works and strives to provide communities with clean drinking water through having installed filter plants
3.3.2. Protecting natural resources
With increased urbanization, natural landscapes of forests and grasslands have quickly turned into urban centres. AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug ensures that all its operational sites are designed in a way that they do not harm or risk the natural ecosystem. In addition, the company works towards protecting the environment by building green spaces.
3.3.3. Safeguarding the environment
The operations of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug, like other players in the industry, are being affected by the climatic changes, and the weather alterations. To fight this change, and to safeguard the environment, AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works towards creating safe green spaces through high rate plantations. This is to ensure environmental sustainability and enrichment of the ecosystem.
4. Value chain at AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug and CSR
At AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug, SCR is embedded in the company DNA. AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug ensures that the CSV approach is integrated into all operations and systems at the company, including THE VALUE CHAIN.
4.1. Supply chain
4.1.1. Rural development
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug allies with farmers and other partners to obtain the high quality raw material. In doing so, the company ensures that it invests in the wellbeing in the development of its partners and related communities through educational opportunities as well as various training programs and infrastructure development.
4.1.2. Responsible sourcing
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug participates in responsible sourcing. All its partners throughout the supply chain and for raw materials have been tested against set ethical backgrounds to ensure that all raw sources and materials are obtained from partners doing sustainable business.
4.1.3. Animal welfare
In all its sourcing, AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug ensures that no animals are harmed. AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug makes sure that all animals are fed high quality fodder, and that they are kept in a clean and safe environment. In addition, AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug also provides safe breeding grounds for animals and regularly authorizes veterinary check-ups for all animals in partner farms.
4.1.4. Human rights
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug is also particularly careful to ensure that all human rights are upheld in its business operations. This includes no child labour, and inclusive diversity, amongst other things. Also, the business operations of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug also include high dependence on local workers for labor and management – making sure all local and global human rights are followed thoroughly.
4.2. Manufacturing
4.2.1. Water, sanitation and hygiene
During the manufacturing process and value additions, AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug maintains an emphasis on water, sanitation and hygiene. All plants and manufacturing units operated by AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug have an authorized sanitation system in place which ensures minimal water wastage. Besides, all industrial waste is disposed of off through authorized channels only – ensuring that no natural water body and water source is harmed or polluted.
4.2.2. Natural resource stewardship
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug is also an active pioneer of natural resource stewardship. AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug has devised ways to ensure that natural resources are sustainably used for industrial operations, and are not damaged during business processes. AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug shares this knowledge publicly for the overall welfare of the environment and the planet.
4.2.3. Women empowerment
During its manufacturing process, the AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug also ensures to employ women labour in various managerial and operational level jobs. These women are usually from local communities and are trained for new skill development and enhancement. In doing so, AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug ensures that women are equipped with the confidence and decision making abilities s that they advance not only in their professional but also in their personal and social lives.
4.3. Retail and consumers
4.3.1. Responsible marketing and influence
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug makes sure to use ethical means of marketing its products. This means not only does it disseminate rightful information and data regarding the company, but also makes sure that it does not use unethical appeals in its marketing communication.
4.3.2. Marketing to children
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug is also careful in its marketing to children so that it is not exploitative. Rather, marketing to children is done through influencing adults towards the products offered by AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug.
4.3.3. Product Safety
AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug ensures product safety in consumption at all times. This is done not only through mentioning nutritional value and facts but also through a clear statement of manufacturing dates and batches. This is to make sure that consumers are aware of the product quality and life cycle. Also, the company mentions clear ways and processes of disposing of the products to ensure that the environment is sustained and not harmed.
5. Working towards achieving sustainable goals
The CSR and CSV approach at AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug is closely guided by the sustainable development goals chalked out by the United Nations. Through working on the attainment of the SDGs, AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug, and many other companies work together to create a peaceful and harmonious future that has sustainable resources and environment.
Through connecting AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug’s goals and commitments with the SDGs, the company has created avenues of channelling a positive impact on society through its operations and business as a whole.
5.1. No poverty
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug creates opportunities for skill enhancement and vocational training
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug also provides equal employment opportunities to all labours from the local communities
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug promotes and supports small business ventures through inclusive business support and funding – especially for women who are micro-entrepreneurs in the community
5.2. Zero hunger
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works towards implementing a model of less food wastage and food loss – in the manufacturing as well as the supply chain process
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug provides subsidized products in communities that are living below the poverty line, as well as in communities where it is operational and has industrial units and sites
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug has developed recycling plants in local communities to ensure that there is no food wasted during consumption, and it is recycled into other products needed for a sustainable environment
5.3. Clean water and sanitation
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug strives to ensure high water efficiency and water sustainability in all business operations and processes
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug advocates and also internally implements positive water policies
- Infrastructure developed by AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug in different rural communities and settlements ensures authorized sewage networks and lines to avoid dumping in freshwater reserves
5.4. Life on land
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works towards establishing the green supply chain
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug ensures that no Green spaces are destroyed for its business and industrial purposes, and also works towards creating healthy green spaces through numerous plantations
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug places a high emphasis on maintaining regular health check-ups for all community members – free of cost, and also focuses on animal welfare for farmers
5.5. Good health and well being
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works towards improving the living standards and quality of life of communities it engages with
- For farmers, AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug has also improved farm economics
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug works towards protecting the children in the supply chain processes, as well as creates diverse livelihood opportunities for adults
5.6. Quality education
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug provides a hands-on learning opportunity for young adults from local communities through internship opportunities
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug also sponsors various scholarship programs for different grade levels in communities where it is operations
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second-Generation Drug has inaugurated primary schools in three different regions where it has operations – in rural settlements – as a step towards achieving quality education for all.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Related Articles
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug 5C Marketing Analysis
- The vision statement of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug
- Organizational Culture of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug Generic and Intensive Growth Strategies
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug Case Study Analysis & Solution
- AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug Case Solution
- Ansoff Matrix of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug
- Blue Ocean Strategy of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug
- Hofstede Cultural Model of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug
- Porters Diamond Model of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug
- Mckinsey 7s Framework Of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug
- Resource Based View Of The Firm - AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug
- VRIN/VRIO Analysis Of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug
- Net Present Value (NPV) Analysis of AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug
- WACC for AstraZeneca Prilosec and Nexium Strategic Challenges in the Launch of a Second Generation Drug
Ma Deming
5.0
Formatting was right and free from an issue. To be honest, I didn't know how to start the paper but this service handled the problem.
Millaim Johnny
5.0
If I hadn't got your expert, the CGPA would have been very low. I'm grateful for your timely favor!
Lotti Jeno
5.0
Pretty awesome staff and a brilliant and experienced writer to his subject. Thank you so much!
Vivian Dominik
5.0
Thank you for revising the assignment on the dot. Always a satisfied client of this service.
Hugo Moritz
5.0
The professor praised me but assigned me another topic of the Strategy to sort out. Please accomplish it like the first one. Thanks a lot!
Wan Liwie
5.0
One of the best satisfactory services that I have. Highly recommended for those who need to complete a Case Study.
Next Articles
- 14746-Inkaterra-Corporate-Social-Responsibility
- 14748-Cyberport-Realisation-of-an-IT-Park-Through-a-Public-Private-Partnership-Corporate-Social-Responsibility
- 14749-Tata-Steel-Zoological-Park-Corporate-Social-Responsibility
- 14750-Assertive-Policing-Plummeting-Crime-The-NYPD-Takes-on-Crime-in-New-York-City-Corporate-Social-Responsibility
- 14751-Uganda-The-Constitution-of-Development-Corporate-Social-Responsibility
- 14752-The-U-S-Federal-Gasoline-Tax-Time-for-a-Change-Corporate-Social-Responsibility
- 14753-Law-Enforcement-and-Unauthorized-Building-Works-Epilogue-For-a-Culture-of-Building-Care-Corporate-Social-Responsibility
- 14754-Conseco-Market-Assumptions-and-Risk-Corporate-Social-Responsibility
- 14755-Protecting-the-WTO-Ministerial-Conference-of-1999-Epilogue-Corporate-Social-Responsibility
- 14756-Building-a-Positive-Future-for-Children-with-Disabilities-through-Strategic-Partnerships-Corporate-Social-Responsibility
Previous Articles
- 1-Making-the-Case-Corporate-Social-Responsibility
- 2-Joe-Smith-s-Closing-Analysis-B-Corporate-Social-Responsibility
- 3-Joe-Smith-s-Closing-Analysis-A-Spanish-Version-Corporate-Social-Responsibility
- 4-GMAC-The-Pipeline-Corporate-Social-Responsibility
- 5-On-Writing-Teaching-Notes-Well-Corporate-Social-Responsibility
- 6-Exxon-Corp-Trouble-at-Valdez-Corporate-Social-Responsibility
- 7-Ashland-Oil-Inc-Trouble-at-Floreffe-A-Corporate-Social-Responsibility
- 8-Ashland-Oil-Inc-Trouble-at-Floreffe-B-Corporate-Social-Responsibility
- 9-Ashland-Oil-Inc-Trouble-at-Floreffe-C-Corporate-Social-Responsibility
- 10-Ashland-Oil-Inc-Trouble-at-Floreffe-D-Corporate-Social-Responsibility
Be a Great Writer or Hire a Greater One!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Essay48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!